Barriers and Enablers to Diabetes Technologies Use Among Individuals With Type 1 Diabetes: A Scoping Review
Authors' conclusion
Barriers to diabetes technology use map to key TDF domains, with structural factors predominating.
Study context
- Population
- Studies of any design on characteristics associated with use of insulin pumps, continuous glucose monitors (CGM) or automated insulin delivery (AID) in individuals with T1D; EMBASE, Cochrane, PubMed and MEDLINE, January 1, 2000 to September 30, 2025
- Participants
- 1,864,469 participants303 studies
- Outcome
- Determinants of diabetes technology use (number of studies)
Methodological detailstheory-informed synthesis using the Theoretical Domains Framework, dual independent screening and extraction, Abstracts 35.3% overall (70.6% of interventions); US-based studies 62.4%; AID-only studies 6.9%
- Theory-informed synthesis using the Theoretical Domains Framework
- Dual independent screening and extraction
- Abstracts 35.3% overall (70.6% of interventions); US-based studies 62.4%; AID-only studies 6.9%
Main finding
As reported in the abstract
- Non-modifiable: racial/ethnic minority status
- n = 90
- Non-modifiable: age
- n = 53
- Non-modifiable: sex
- n = 36
- Non-modifiable: socioeconomic status
- n = 40
- Barrier: financial constraints
- n = 117
- Barrier: provider gatekeeping and clinic processes
- n = 43
- Barrier: physical burden or body image concerns
- n = 41
- Enabler: supportive patient-provider relationships and shared decision-making
- n = 42
- Enabler: patient education and knowledge of device benefits
- n = 40
- Enabler: proactive provider engagement
- n = 24
Original publication
Barriers and Enablers to Diabetes Technologies Use Among Individuals With Type 1 Diabetes: A Scoping Review. Diabetes Obes Metab. Published 5 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →